Residency · Residency · Dermatology
Central Centrifugal Cicatricial Alopecia and Traction Alopecia
Introduction
Central centrifugal cicatricial alopecia (CCCA) and traction alopecia are the most common causes of hair loss in women of African descent. Both are preventable and treatable when recognized early, yet frequently progress to permanent hair loss due to delayed diagnosis. Understanding the interplay of genetic predisposition, hair care practices, and inflammatory mechanisms is critical for effective counseling and management.
Central Centrifugal Cicatricial Alopecia (CCCA)
Epidemiology
CCCA is the most prevalent scarring alopecia in women of African descent, though it can occur in any ethnicity. The estimated prevalence among African American women is approximately 5.6%. It predominantly affects women aged 30 to 60 and is rare in men. Although historically attributed solely to hair care practices, emerging genetic evidence reveals an underlying susceptibility that is now recognized as fundamental to the disease.
Pathogenesis
PADI3 mutations (loss-of-function variants in the peptidylarginine deiminase 3 gene) have been identified in a significant proportion of CCCA patients. The PADI3 enzyme citrullinates hair shaft structural proteins, and its deficiency leads to premature desquamation of the inner root sheath and hair shaft fragility. This premature inner root sheath desquamation (PISD) is the earliest histopathologic finding and is present even in clinically unaffected scalp of CCCA patients. Hair care practices such as chemical relaxers, hot combs, and tight hairstyles likely act as environmental triggers in genetically susceptible individuals rather than serving as sole causative agents. Progressive lymphocytic inflammation around the isthmus and infundibulum leads to destruction of the follicular bulge stem cell niche and irreversible follicular dropout.
Clinical Features
The process begins at the vertex/crown and expands centrifugally (outward in all directions). Early findings include subtle thinning at the crown with decreased hair density, and individual hairs may appear lusterless and fragile. As the disease progresses, an expanding patch of smooth, shiny, scarred scalp develops with loss of follicular ostia. Tenderness, burning, and pruritus at the active margin are important symptoms to elicit during history-taking. A polymorphous hair appearance with breakage at varying lengths is seen within the affected area. CCCA may coexist with uterine leiomyomas (fibroids) due to shared PADI3 genetic susceptibility, and affected patients should be screened.
Trichoscopy
The cardinal sign is loss of follicular ostia, which are replaced by white or pale dots. A peripilar white-gray halo (peripilar sign) represents concentric white scaling around residual hair shafts, reflecting perifollicular fibrosis. Pinpoint white dots indicate replacement of follicular openings by fibrous tracts. Hair shaft variability with broken hairs, thin hairs, and single-hair units is evident, and disruption of the honeycomb pigment pattern may be seen in the surrounding scalp.
Histopathology
The earliest and most characteristic finding is premature desquamation of the inner root sheath. Perifollicular lymphocytic inflammation is centered on the isthmus and infundibulum. Lamellar fibroplasia (concentric fibrosis) surrounds affected follicles, with progressive replacement of follicles by fibrous tracts. In advanced disease, compound follicles with naked hair shafts surrounded by foreign body giant cells are seen. The biopsy technique requires two 4 mm punches, one processed horizontally and one vertically, taken from the active margin rather than the center of the alopecic patch.
<image>Clinical photograph of CCCA showing vertex-centered scarring alopecia with progressive centrifugal expansion, smooth shiny scalp centrally with loss of follicular ostia, and trichoscopy inset showing peripilar white-gray halos and pinpoint white dots</image>
Management
Anti-Inflammatory Therapy (Active Disease)
Potent topical corticosteroids (clobetasol 0.05% solution or foam) applied to the active margins twice daily form the backbone of therapy. Intralesional triamcinolone acetonide (5 to 10 mg/mL) is injected into the active margin every 4 to 6 weeks. Oral doxycycline or minocycline (100 mg daily) provides anti-inflammatory benefit and is a useful adjunct for symptomatic disease. Hydroxychloroquine (200 to 400 mg daily) is used for progressive disease unresponsive to topical and intralesional therapy. Mycophenolate mofetil is reserved for refractory, rapidly progressive CCCA.
Adjunctive Therapy
Topical minoxidil 5% promotes regrowth in non-scarred follicles at the periphery but does not reverse scarring. Low-dose oral minoxidil is an emerging adjunctive option.
Hair Care Modifications
Patients should minimize chemical processing by reducing the frequency of relaxers and considering transitioning to natural hairstyles. Excessive heat from flat irons and blow dryers should be limited, with heat protectants used when heat styling is necessary. Mechanical tension from tight braids, weaves, and extensions should be reduced, particularly at the vertex. Gentle shampooing and conditioning with regular moisturizing and avoidance of excessive manipulation is advised. It is critical to emphasize that hair care modification alone is insufficient in the setting of active inflammation, and concurrent anti-inflammatory treatment is essential.
Traction Alopecia
Pathogenesis
Traction alopecia results from chronic, repetitive mechanical tension on hair follicles from styling practices. Sustained traction causes perifollicular inflammation, progressive follicular damage, and eventually permanent follicular destruction. The process is initially reversible (non-scarring) but becomes irreversible (scarring) if traction is not eliminated before follicular destruction occurs.
Risk Factors and Hair Practices
High-risk practices include tight braids, cornrows, locs, weaves, and extensions, especially when applied to the frontotemporal hairline ("edges"). Ponytails, buns, and updos with chronic tension are also implicated. Chemical relaxation combined with traction significantly amplifies risk. Cultural and occupational factors contribute, including practices among dancers, Sikh men (tight turbans), and athletes. Children are especially vulnerable because developing follicles are more susceptible to traction injury.
Clinical Features
The most characteristic pattern is frontotemporal hairline recession, with loss of "baby hairs" along the hairline. Marginal alopecia along the peripheral hairline is the hallmark distribution. The fringe sign describes the retention of fine vellus hairs along the anterior hairline and indicates the disease is at a non-scarring, potentially reversible stage. Perifollicular papules and pustules at sites of traction indicate active folliculitis. In advanced disease, smooth, scarred margins devoid of follicular ostia are present.
Diagnosis
The diagnosis is clinical, based on the pattern, history of traction hairstyles, and preservation of the fringe sign. Trichoscopy reveals hair casts (cylindrical concretions), broken hairs, reduced follicular density at affected margins, and miniaturized hairs. Biopsy is rarely needed but shows decreased follicular density, trichomalacia (distorted hair shafts within follicles), mild perifollicular inflammation in early disease, and fibrosis with follicular dropout in late disease.
Management
Hair practice modification is the cornerstone: traction hairstyles should be discontinued and loose, protective styles adopted. Early intervention is critical, as the condition is reversible in early stages when the fringe sign is present. Topical minoxidil 5% promotes regrowth of miniaturized follicles in the reversible stage. Intralesional triamcinolone (2.5 to 5 mg/mL) is indicated for areas with active perifollicular inflammation. Topical corticosteroids address inflammatory papules and pustules at the traction margin. Oral antibiotics (doxycycline) are used for associated folliculitis. Hair transplantation is a viable option for stable, burned-out traction alopecia with scarring, and success rates are good if traction practices are permanently modified. Patient and community education with culturally sensitive counseling regarding protective hairstyles and engagement with stylists as partners in prevention is essential.
<image>Clinical photographs comparing early traction alopecia showing frontotemporal recession with preserved fringe sign (vellus hairs along the hairline) versus late traction alopecia with smooth scarring and complete loss of follicular ostia along the hairline margin</image>
CCCA vs. Traction Alopecia: Key Distinctions
| Feature | CCCA | Traction Alopecia |
|---|---|---|
| Location | Vertex/crown | Frontotemporal margins |
| Pattern | Centrifugal expansion | Marginal recession |
| Fringe sign | Absent | Present (early disease) |
| Genetic basis | PADI3 mutations | None identified |
| Primary mechanism | Autoimmune/inflammatory | Mechanical |
| Associated conditions | Uterine fibroids | None |
Key Clinical Pearls
CCCA is not simply a consequence of hair care practices. PADI3 mutations establish a genetic basis, and hair practices serve as environmental modifiers. The presence of the fringe sign in traction alopecia indicates reversible disease, representing the critical window for intervention. Biopsy for CCCA should be taken from the active margin (not the scarred center) and processed with horizontal sections for optimal diagnostic yield. CCCA patients should be screened for uterine leiomyomas given the shared PADI3 pathophysiology. Culturally competent counseling is essential, engaging patients collaboratively in modifying hair practices without dismissing the cultural significance of hairstyles.
<image>Side-by-side diagram showing scalp distribution patterns: CCCA centered at the vertex with centrifugal expansion arrows, versus traction alopecia along the frontotemporal and marginal hairline with arrows indicating the direction of traction force</image>
References
- Malki L, Sarig O, Romano MT, et al. Variant PADI3 in central centrifugal cicatricial alopecia. N Engl J Med. 2019;380(9):833-841.
- Olsen EA, Callender V, McMichael A, et al. Central hair loss in African American women: incidence and potential risk factors. J Am Acad Dermatol. 2011;64(2):245-252.
- Samrao A, Price VH, Zedek D, Mirmirani P. The "fringe sign" — a useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J. 2011;17(11):1.
- Haskin A, Aguh C. All hairstyles are not created equal: what the dermatologist needs to know about Black hairstyling practices and the risk of traction alopecia. J Am Acad Dermatol. 2016;75(3):606-611.
